In our study, we report a complex of PM and HP-β-CD (PM/HP-β-CD) to generate lyophilised powder soluble in normal saline to improve the solubility, while maintaining the anti-tumour activity of PM as an HDAC inhibitor. Here, HDAC9 is linked to neoplasm.